We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
Cap. Flow
-$715M
Cap. Flow %
-2.15%
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$29M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$14M
3
MSFT icon
Microsoft
MSFT
+$10.8M
4
META icon
Meta Platforms (Facebook)
META
+$10.5M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$6.72M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.4M
2
FRX
FOREST LABORATORIES INC
FRX
+$32.2M
3
XOM icon
ExxonMobil
XOM
+$23.9M
4
WBD icon
Warner Bros
WBD
+$15.4M
5
RTX icon
RTX Corp
RTX
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 14.81%
2 Financials 14.8%
3 Healthcare 13.73%
4 Industrials 10.72%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CERS icon
2676
Cerus
CERS
$441M
$227K ﹤0.01%
56,486
– –
TBNK
2677
DELISTED
Territorial Bancorp Inc.
TBNK
$227K ﹤0.01%
11,170
– –
FRM
2678
DELISTED
FURMANITE CORPORATION COM
FRM
$226K ﹤0.01%
33,425
– –
CAS
2679
DELISTED
A M Castle & Co
CAS
$226K ﹤0.01%
26,427
– –
AOSL icon
2680
Alpha and Omega Semiconductor
AOSL
$1.01B
$224K ﹤0.01%
23,851
– –
MLR icon
2681
Miller Industries
MLR
$579M
$224K ﹤0.01%
13,257
+75
+0.6% +$1.44K
RIGL icon
2682
Rigel Pharmaceuticals
RIGL
$716M
$223K ﹤0.01%
11,477
– –
NNA
2683
DELISTED
Navios Maritime Acquisition Corporation
NNA
$223K ﹤0.01%
5,485
– –
BBRG
2684
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$223K ﹤0.01%
17,220
+500
+3% +$7.29K
CACB
2685
DELISTED
Cascade Bancorp
CACB
$223K ﹤0.01%
44,124
+1,500
+4% +$7.87K
AHRT
2686
AH Realty Trust
AHRT
$539M
$222K ﹤0.01%
24,488
– –
PGC icon
2687
Peapack-Gladstone Financial
PGC
$827M
$222K ﹤0.01%
12,676
+400
+3% +$7.57K
PAHC icon
2688
Phibro Animal Health
PAHC
$1.48B
$221K ﹤0.01%
9,880
– –
PSIX
2689
Power Solutions International
PSIX
$804M
$221K ﹤0.01%
3,202
– –
USAP
2690
DELISTED
Universal Stainless & Alloy
USAP
$221K ﹤0.01%
8,383
– –
CUNB
2691
DELISTED
CU Bancorp
CUNB
$221K ﹤0.01%
11,776
– –
OSIR
2692
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$221K ﹤0.01%
17,559
+200
+1% +$2.85K
RENX
2693
DELISTED
RELX N.V.
RENX
$221K ﹤0.01%
15,037
– –
AP icon
2694
Ampco-Pittsburgh
AP
$183M
$220K ﹤0.01%
10,985
– –
NUTR
2695
DELISTED
Nutraceutical International Co
NUTR
$220K ﹤0.01%
10,525
– –
BRFS
2696
DELISTED
BRF SA
BRFS
$219K ﹤0.01%
9,200
– –
IMO icon
2697
Imperial Oil
IMO
$61.6B
$219K ﹤0.01%
4,640
– –
TSC
2698
DELISTED
TriState Capital Holdings, Inc.
TSC
$219K ﹤0.01%
24,108
– –
FUEL
2699
DELISTED
Rocket Fuel Inc.
FUEL
$219K ﹤0.01%
13,844
-60
-0.4% -$1.15K
LIOX
2700
DELISTED
Lionbridge Technologies
LIOX
$218K ﹤0.01%
48,487
– –
106 107
108
109 110

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
  • RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
  • RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
  • RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
  • RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
  • RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.